CytomX Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

NEXT STORY
Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma
PREV STORY
Draganfly Unveils Latest Vital Intelligence Smart Vital Kiosk During CES
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Recro Pharma Submits New Drug Application for IV Meloxicam 30mg

MALVERN, Pa., July 31, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue ...

author_avatar
NASDAQ Market News

SELLAS Life Sciences Completes Second Tranche of $10,700,000 Private Placement

Proceeds used towards advancement of clinical programs NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) ...

author_avatar
NASDAQ Market News

Spring Bank Pharmaceuticals to Host R&D Day on Thursday, December 6, 2018

HOPKINTON, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), ...

author_avatar
NASDAQ Market News